MyStocks

MEMBER'S LOGINX

Remember Username
Keep me signed in

(Please do not use this option on a public machine)

Home
Research It
CADILA HEALTHCARE LIMITED (pharmaceuticals)
CADILA HEALTHCARE LIMITED Financial Data

Cadila Healthcare Fact Sheet (CADIL)

Mail
Print
FaceBook
Twitter
Linked In
WhatsApp

Here is the latest financial fact sheet of Cadila Healthcare. For more details, see the Cadila Healthcare quarterly results and Cadila Healthcare share price and chart. For a sector overview, read our pharmaceuticals sector report.

CADILA HEALTHCARE Price History

Price	Rs	314.5
Mkt Cap	Rs m	321,966
Vol	'000	23.1
P/E	X	16.4
P/CF	X	14.0
EPS (TTM)	Rs	19.2

% ch	%	0.4
No. of shares	m	1,023.74
% ch week	%	0.0
% ch 1-mth	%	-8.9
% ch 12-mth	%	-21.5
52 week H/L	Rs	432.4/306.4

(As on Feb 22, 2019 (Close))

» Best Performing pharmaceuticals Stocks

1d 1w 1m 3m 6m 1y 3y 5y Max

* Results Consolidated

EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

CADILA HEALTHCARE Financials

No. of Mths Year Ending	12 Mar-14*	12 Mar-15*	12 Mar-16*	12 Mar-17*	12 Mar-18*	5-Yr Chart Click to enlarge

CADILA HEALTHCARE EQUITY SHARE DATA
High	Rs	1,079	1,763	454	460	558
Low	Rs	631	872	305	305	362
Sales per share (Unadj.)	Rs	352.8	422.5	92.1	91.6	116.3
Earnings per share (Unadj.)	Rs	39.2	56.2	19.2	14.8	17.9
Diluted earnings per share	Rs	7.8	11.2	19.2	14.8	17.9
Cash flow per share (Unadj.)	Rs	49.1	70.2	22.0	18.5	23.1
Dividends per share (Unadj.)	Rs	9.00	12.00	3.20	3.20	3.50
Adj. dividends per share	Rs	1.80	2.40	3.20	3.20	3.50
Dividend yield (eoy)	%	1.1	0.9	0.8	0.8	0.8
Book value per share (Unadj.)	Rs	168.0	220.8	55.7	68.0	85.4
Adj. book value per share	Rs	33.6	44.2	55.7	68.0	85.4
Shares outstanding (eoy)	m	204.75	204.75	1,023.74	1,023.74	1,023.74
Bonus/Rights/Conversions		-	-	FV5:1	-	-
Price / Sales ratio	x	2.4	3.1	4.1	4.2	4.0
Avg P/E ratio	x	21.8	23.4	19.8	25.8	25.7
P/CF ratio (eoy)	x	17.4	18.8	17.2	20.7	19.9
Price / Book Value ratio	x	5.1	6.0	6.8	5.6	5.4
Dividend payout	%	22.9	21.4	16.7	21.6	19.6
Avg Mkt Cap	Rs m	175,061	269,758	388,458	391,581	470,664
No. of employees	`000	12.2	13.2	15.4	16.9	11.8
Total wages/salary	Rs m	10,711	12,085	12,616	15,198	18,545
Avg. sales/employee	Rs Th	5,908.2	6,564.0	6,105.0	5,563.0	10,072.7
Avg. wages/employee	Rs Th	876.0	916.9	817.0	901.7	1,569.1
Avg. net profit/employee	Rs Th	657.2	873.0	1,272.1	901.5	1,547.7

CADILA HEALTHCARE INCOME DATA
Net Sales	Rs m	72,240	86,513	94,268	93,765	119,049
Other income	Rs m	507	554	1,156	1,284	1,132
Total revenues	Rs m	72,747	87,067	95,424	95,049	120,181
Gross profit	Rs m	12,001	17,599	23,305	19,044	28,475
Depreciation	Rs m	2,012	2,873	2,921	3,733	5,388
Interest	Rs m	902	679	528	446	911
Profit before tax	Rs m	9,594	14,601	21,012	16,149	23,308
Minority Interest	Rs m	-326	-397	430	338	628
Prior Period Items	Rs m	265	42	0	0	0
Extraordinary Inc (Exp)	Rs m	-172	-104	-25	-3	0
Tax	Rs m	1,325	2,636	1,774	1,289	5,644
Profit after tax	Rs m	8,036	11,506	19,643	15,195	18,292
Gross profit margin	%	16.6	20.3	24.7	20.3	23.9
Effective tax rate	%	13.8	18.1	8.4	8.0	24.2
Net profit margin	%	11.1	13.3	20.8	16.2	15.4

CADILA HEALTHCARE BALANCE SHEET DATA
Current assets	Rs m	34,379	40,887	42,804	60,223	82,005
Current liabilities	Rs m	28,140	29,921	34,610	53,058	60,720
Net working cap to sales	%	8.6	12.7	8.7	7.6	17.9
Current ratio	x	1.2	1.4	1.2	1.1	1.4
Inventory Days	Days	69	60	52	70	73
Debtors Days	Days	57	69	68	89	98
Net fixed assets	Rs m	40,153	40,526	46,987	72,984	83,703
Share capital	Rs m	1,024	1,024	1,024	1,024	1,024
"Free" reserves	Rs m	27,845	44,184	55,968	68,576	86,421
Net worth	Rs m	34,390	45,208	56,992	69,600	87,445
Long term debt	Rs m	13,622	11,504	8,964	24,684	25,551
Total assets	Rs m	79,865	91,342	105,506	152,207	180,653
Interest coverage	x	11.6	22.5	40.8	37.2	26.6
Debt to equity ratio	x	0.4	0.3	0.2	0.4	0.3
Sales to assets ratio	x	0.9	0.9	0.9	0.6	0.7
Return on assets	%	11.2	13.3	19.1	10.3	10.6
Return on equity	%	23.4	25.5	34.5	21.8	20.9
Return on capital	%	21.4	26.1	33.3	18.0	22.0
Exports to sales	%	27.7	32.5	47.2	0	0
Imports to sales	%	5.8	6.2	6.2	0	0
Exports (fob)	Rs m	20,038	28,080	44,537	0	0
Imports (cif)	Rs m	4,210	5,391	5,838	0	0
Fx inflow	Rs m	20,613	29,666	44,881	21,280	42,683
Fx outflow	Rs m	6,864	8,093	9,069	10,874	11,242
Net fx	Rs m	13,749	21,573	35,812	10,406	31,441

CADILA HEALTHCARE CASH FLOW
From Operations	Rs m	9,028	9,936	18,935	13,117	9,193
From Investments	Rs m	-4,380	-4,647	-8,635	-28,719	-9,737
From Financial Activity	Rs m	-5,287	-3,511	-9,348	23,158	515
Net Cashflow	Rs m	-639	1,778	991	7,556	-29

* Results Consolidated

Source: Company Annual Reports, Regulatory Filings, Equitymaster

» Historical quarterly results for cadila healthcare limited

Share Holding

Indian Promoters	74.8%
Foreign collaborators	0.0%
Indian inst/Mut Fund	8.3%
FIIs	5.9%
ADR/GDR	0.0%
Free float	11.0%
Shareholders	44,069
Pledged promoter(s) holding	0.0%

Today's Market

Recapitalisation Package for PSBs: The Pros & Cons(Podcast)

Corporate governance issues with certain companies, uncertainty surrounding national elections and global issues like trade wars, Brexit, have taken a toll on the Indian markets.

Views on news

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

The 4-Point Plan to Accelerate India to a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Feb 12, 2019

Two questions I have been eagerly waiting to ask you ever since Budget 2019 was announced.

The Train to 'Small-Cap-Profits Land' is Back on the Station!(Profit Hunter)

Feb 15, 2019

Why its great news that prices for small caps over the last few days have been falling like there's no tomorrow.

Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
Add To MyStocks

CADILA HEALTHCARE - ACTAVIS COMPARISON

Compare Company With Charts

COMPARE CADILA HEALTHCARE WITH

MARKET STATS

ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

FREE NEWSLETTERS

PREMIUM PRODUCTS

QUICK LINKS

APPS

FOLLOW

Follow @Equitymaster

Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

Testimonials